Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL

References

• Hahne M, Kataoka T, Schröter M, Hofmann K,ler M, Bod-mer JL, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med. 1998;188: 1185–90.
   Google Scholar
• Kelly K, Manos E, Jensen G, Nadauld L, Jones DA. APRIL/ TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 2000;60: 1021–7.
   Google Scholar
• Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casafi P, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002; 3:822–9.
   PubMed Web of Science ®Google Scholar
• Dillon SR, Gross JA, Anse11 SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov. 2006;5: 235–46.
   Google Scholar
• Koyama T, Tsukamoto H, Miyagi Y, Himeji D, Otsuka J, Miyagawa H, et al. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis. 2005;64:1065–7.
   PubMed Web of Science ®Google Scholar
• Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003;48:982–92.
   PubMed Web of Science ®Google Scholar
• Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in pri-mary Sjogren's syndrome. J Clin Immunol. 2005;25:189–201.
   Google Scholar
• Thangarajh M, Masterman T, Rot U, Duvefelt K, Brynedal B, Karrenbauer VD, et al. Increased levels of APRIL (a prolifera-tion-inducing ligand) mRNA in multiple sclerosis. J Neuroim-munol. 2005;167:210–4.
   PubMed Web of Science ®Google Scholar
• Koyama T, Tsukamoto H, Masumoto K, Himeji D, Hayashi K, Harada M, et al. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheuma-tology. 2003;42:980–5.
   PubMed Web of Science ®Google Scholar
• Kawasaki A, Tsuchiya N, Ohashi J, Murakami Y, Fukazawa T, Kusaoi M, et al. Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese. Rheumatology. 2007;46:776–82.
   PubMedGoogle Scholar
• Lee YH, Ota F, Kim-Howard X, Kaufman KM, Nath SK. APRIL polymorphism and systemic lupus erythematosus (SLE) suscep-tibility. Rheumatology. 2007;46:1274–6.
   Google Scholar
• Shu HB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol. 1999;65: 680–3.
   Google Scholar
• Zhang J, Roschke V, Baker KP, Wang Z, Alarcón GS, Fessler BJ, et al. Cutting edge: a role for B lymphocyte stimulator in sys-temic lupus erythematosus. J Immunol. 2001;166:6–10.
   Google Scholar
• Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, et al. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active sys-temic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Rheumatology. 2007; 46:1083–6.
   PubMed Web of Science ®Google Scholar
• Davidson A. Targeting BAFF in autoimmunity. Curr Opin Immunol. 2010;22:732–9.
   PubMed Web of Science ®Google Scholar
• Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189:1747–56.
   PubMed Web of Science ®Google Scholar
• López-Fraga M, Fernández R, Albar JP, Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2001;2:945–51.
   PubMed Web of Science ®Google Scholar
• Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000; 404:995–9.
   PubMed Web of Science ®Google Scholar
• Yu G, Boone T, Delaney J, Hawkins N, Kelley M, Ramakrishnan M, et al. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat Immunol. 2000;1:252–6.
   PubMed Web of Science ®Google Scholar
• Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, et al. BAFF-R, a newly identified TNF receptor that spe-cifically interacts with BAFF. Science. 2001;293:2108–11.
   PubMed Web of Science ®Google Scholar
• Yan M, Brady JR, Chan B, Lee WP, Hsu B, Harless S, Cancro M, Grewal IS, Dixit VM. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol. 2001;11:1547–52.
   Google Scholar
• IngoId K, Zumsteg A, Tardivel A, Huard B, Steiner QG, Cachero TG, et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med. 2005;201:1375–83.
   PubMedGoogle Scholar
• Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood. 2007;109:2961–7.
   PubMed Web of Science ®Google Scholar
• Tian S. A 20 residues motif delineates the furin cleavage site and its physical properties may influence viral fusion. Biochem Insights. 2009;2:9–20.
   Google Scholar
• Gavin AL, Ait-Azzouzene D, Ware CF, Nemazee D. ABAFF, an alternate splice isoform regulates receptor binding biopresenta-tion of B cell survival cytokine. J Biol Chem. 2003;278:38220–8.
   PubMedGoogle Scholar
• Rennert P, Schneider P, Cachero TG, Thompson J, Trabach L, Hertig S, et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med. 2000;192:1677–84.
   PubMed Web of Science ®Google Scholar
• Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol. 2006;18: 263–75.
   PubMed Web of Science ®Google Scholar